NCT03462849View on ClinicalTrials.gov

Expiratory Flow Limitation Assessment

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions
Acute Respiratory Distress Syndrome
Interventions
OTHER

increase in positive end expiratory pressure

increase in positive end expiratory pressure from 5 to 10 then 15 cmH2O then at the value for trans pulmonary end expiratory pressure amounting to 3 cmH2O

Trial Locations (2)

69004

Hôpital de la Croix Rousse, Lyon

Unknown

CHU Grenoble Alpes, Grenoble

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03462849 - Expiratory Flow Limitation Assessment | Biotech Hunter | Biotech Hunter